Oracle’s Q3 and Outlook Fall Short of Our Expectations

Oracle’s third quarter was marked by some bright spots but ultimately came in as a disappointment.

Securities In This Article
Oracle Corp
(ORCL)

Oracle’s ORCL third quarter was marked by some bright spots--like in Oracle's Fusion cloud ERP and HCM offering--but ultimately came in as a disappointment. Oracle missed our top and bottom line expectations, with gross profit significantly contributing to the discrepancy. Coupled with results was the outlook for the upcoming fourth quarter, which was also underwhelming. Outlook assumed Cerner would be acquired after the upcoming fourth quarter. In our model, we assume the deal will close at the beginning of Oracle's fiscal 2023 and we continue to believe that the deal leaves much to be desired, with little synergies in sight. All considered, we are maintaining our fair value estimate for the narrow-moat stock at $63 per share. This leaves Oracle overvalued with shares trading at $76 in after hours.

Revenue in the third quarter increased 4% year over year to $10.5 billion, as cloud services and license support sales continued to drive results, reaching $7.6 billion in the quarter, representing a 5% increase year over year. Within the largest segment, Oracle reported much health seen in its strategic back-office applications as well as Fusion ERP, Fusion HCM, and Netsuite ERP. Oracle’s cloud license and on-premise license revue growth was mild at 1% year over year, leading to $1.3 billion in revenue. On profitability, adjusted operating margins for the quarter expanded by 100 basis points year over year to 46% and non-GAAP earnings per share were $1.13.

Outlook for the fourth quarter includes revenue growth of 4% and adjusted earnings per share of $1.42, both at the midpoint. Guidance assumes that Oracle's acquisition of Cerner happens after Oracle's fourth quarter.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Stocks

About the Author

Julie Bhusal Sharma

Equity Analyst
More from Author

Julie Bhusal Sharma is an equity analyst, AM Technology, for Morningstar*. She has covered enterprise software and IT services firms since 2019, ranging from Oracle and Workday to IBM and Accenture. When she’s not analyzing the fast-moving technology sector, she serves as co-chair of Morningstar Equity Research’s Diversity, Equity and Inclusion committee, where she focuses on improving equity and inclusion throughout the department.

Before joining Morningstar in 2017, Bhusal Sharma freelanced for the Chicago Tribune, writing about tech and startups for their Blue Sky section. She also was acting associate editor for Columbus CEO, and her column for that magazine won the Alliance of Area Business Publishers’ national award for “Best Recurring Feature” in 2017.

Bhusal Sharma holds a bachelor’s degree in philosophy with a minor in mathematics from Kenyon College, where she was a magna cum laude graduate. She also holds an MBA, with honors, from University of Chicago Booth School of Business.

* Morningstar Research Services LLC (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc

Sponsor Center